Risk register — Lightwave Logic (LWLG)

Compiled risks from technical, commercial, capital, governance, market, and macro categories. Each risk is rated by likelihood (L/M/H) and impact (L/M/H).

Risk matrix — likelihood × impact

37 risks · 7 categories · top-right quadrant = highest risk

Technical Customer Foundry Capital IP Competitive Market · hover any dot for full risk text

10-K risk-factor diff · FY2024 → FY2025

Lebby's last filing → LeMaitre's first

FY24 risks

filed Mar 2025

FY25 risks

filed Mar 2026

Added

net-new in FY25

Removed

dropped from FY24

Reworded

36 stable

Analyst takeaways

Named key-personnel risk reshuffled: FY24 listed CEO LeMaitre, President Zelibor, and CFO/COO Marcelli; FY25 lists CEO LeMaitre, CTO Aref Chowdhury, VP Engineering Lance Thompson, and SVP Sales Robert Blum. Zelibor and Marcelli are no longer flagged as key-person risks - signaling either (a) reduced reliance on the C-suite carryover from the Lebby era, or (b) a deliberate pivot in the named-risk set toward technical and commercial leadership ahead of the commercialization phase.
Cash runway extended materially: FY24 disclosed sufficient funds 'through April 2026'; FY25 says 'through at least December 2027' - roughly 20 additional months of runway. However, the operating-loss horizon was also pushed out from 'through at least 2025' to 'through at least 2027' - management is conceding profitability is further away than originally targeted. Accumulated deficit $167.3M; FY25 net loss $20.3M (vs $22.5M FY24, $21.0M FY23).
Capital-source disclosure simplified: FY24 listed two Lincoln Park purchase agreements (2023 + 2025, each $30M) plus the Roth $35M ATM; FY25 mentions ONLY the Roth Sales Agreement with $12.2M remaining capacity. The 2025 Lincoln Park facility was apparently retired or unused. Combined with a smaller share-overhang risk paragraph (the FY24 reference to 'shareholders that accumulated their shares...at significantly less than our current share prices' was removed), this reads as a tightening of disclosed dilution channels to one named ATM.
FY24 risk factor 'We may incur debt in the future that might be secured with our intellectual property as collateral' was removed entirely in FY25 - either management has explicitly committed to never pledging IP, or they assess this as no longer a credible scenario. Either way, this is a small derisk for IP holders.
FY24 'requirements of being a public company are a strain on our systems and resources' was dropped - boilerplate cleanup, not a material signal but reflects LeMaitre's tighter editorial pen versus Lebby-era filings.
Total risks went 42 to 40, with zero net-new risks introduced. The absence of any new disclosed risk under LeMaitre's first full sign-off cycle is itself notable - no Marvell-Polariton concentration risk, no AI/datacenter customer-concentration risk, no foundry/Tower/Polariton single-supplier risk. Either management does not yet view these ecosystem dependencies as material enough to disclose, or they are subsumed under existing partner/joint-venture language.

− Removed from FY25 (2)

We may incur debt in the future that might be secured with our intellectual property as collateral, which could subject our Company to the risk of loss of all of our intellectual property.

We currently have no debt to service. If we incur debt in the future, we may be required to secure the debt with our intellectual property, including all of our patents and patents pending. In the event we default on the debt, we could incur the loss of all of our intellectual property, which would materially and adversely affect our Company and cause you to lose your entire investment in our Company.

The requirements of being a public company are a strain on our systems and resources, are a diversion to management’s attention and are costly.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934 (“ Exchange Act ”) the Sarbanes-Oxley Act of 2002 (“ Sarbanes-Oxley Act ”), the Dodd-Frank Wall Street Reform and Consumer Protection Act (“ Dodd-Frank Act ”), and the rules and regulations of The NASDAQ Stock Market. The requirements of these rules and regulations increase our legal, accounting and financial compliance costs, make some activities more difficult, time-consuming and costly and

≠ Reworded (4)

We have incurred substantial operating losses since our inception and will continue to incur substantial operating losses for the foreseeable future.

FY24

Since our inception, we have been engaged primarily in the research and development of our electro-optic polymer materials technologies and products. As a result of these activities, we incurred significant losses and experienced negative cash flow since our inception. We incurred a net loss of $22,535,041 for the year…

FY25

Since our inception, we have been engaged primarily in the research and development of our electro-optic polymer materials technologies and products. As a result of these activities, we have incurred significant losses and have experienced negative cash flow since our inception. We incurred a net loss of $20,313,797 fo…

Jaccard similarity: 86%

We will require additional capital to continue to fund our operations and if we do not obtain additional capital, we may be required to substantially limit our operations.

FY24

Our business does not presently generate the cash needed to finance our current and anticipated operations. Based on our current operating plan and budgeted cash requirements, we believe that we have sufficient funds to finance our operations through April 2026; however, we will need to obtain additional future financi…

FY25

Our business does not presently generate the cash needed to finance our current and anticipated operations. Based on our current operating plan and budgeted cash requirements, we believe that we have sufficient funds to finance our operations through at least December 2027; however, we will need to obtain additional fu…

Jaccard similarity: 85%

The loss of certain of our key personnel, or any inability to attract and retain additional personnel, could impair our ability to attain our business objectives.

FY24

Our future success depends to a significant extent on the continued service of our key management personnel, particularly Yves LeMaitre, our Chief Executive Officer, Thomas E. Zelibor, our President and James S. Marcelli our Chief Financial Officer, Chief Operating Officer, and Secretary. Accordingly, the loss of the s…

FY25

Our future success depends to a significant extent on the continued service of our key management personnel, particularly Yves LeMaitre, our Chief Executive Officer, Aref Chowdhury, Chief Technology Officer, Lance Thompson, Vice President of Engineering, and Robert Blum, Senior Vice President of Sales. Accordingly, the…

Jaccard similarity: 81%

A sale of a substantial number of shares of our common stock may cause the price of our common stock to decline and may impair our ability to raise capital in the future.

FY24

Our common stock is traded on The NASDAQ Capital Market and, despite certain increases of trading volume from time to time, there have been periods when the market for our common stock could be considered “thinly-traded,” meaning that the number of persons interested in purchasing our common stock at or near bid prices…

FY25

Jaccard similarity: 66%

Source: 2025-03-18 10-K → 2026-03-20 10-K (Item 1A). Matched by Jaccard text similarity.

Technical risks

#	Risk	Likelihood	Impact	Notes / mitigants
T1	Wafer-scale yield insufficient for foundry economics	M	H	Telcordia + 2000h reliability data are encouraging; yield at >100mm² wafer remains undemonstrated publicly
T2	Photo-stability fails under CW high-power CPO duty cycle	L-M	H	Encapsulation (4th-gen ALD, OTR 1.4×10⁻⁶) addresses this; no independent third-party validation yet
T3	Glass-transition temperature drift over service life	L	M	Tg=185°C is well above CMOS BEOL; community-cited risk but Telcordia pass mitigates
T4	RF impedance / drive-electronics co-design at 800G+	M	M	LWLG slot waveguide is well-understood at sub-1V drive; 400G+ scaling needs new driver-IC integration
T5	Reliability failure mode discovered during qualification (yield kill)	L-M	H	LWLG has accumulated 5,000h aging on packaged 200 Gbps; remaining shock/vibration “not difficult” per community read
T6	TFLN cost-curve descends faster than EOP, locking customer roadmaps	M-H	M-H	TFLN already at 1M die/yr at 90% yield (HyperLight); window for EOP is tight

Customer / commercial risks

#	Risk	Likelihood	Impact	Notes / mitigants
C1	Stage-3 customer departure (1 of 4)	M	M-H	25% pipeline shock; partially mitigated by 15+ Stage-1/2 cohort
C2	Customer takes 24-30 months instead of 12-18 to reach Stage-4	M-H	M	Funding bridge required; ATM dilution risk amplifies
C3	Customer commits to Stage-4 with NLM Photonics (Selerion) instead of LWLG	L-M	H	NLM’s r33 (150-450 pm/V) is competitive; mitigant is LWLG’s foundry-PDK first-mover position
C4	Hyperscaler chooses in-house chemistry path	L	H	Hyperscalers (Google, Microsoft) have historically not built materials chemistry in-house; lower-likelihood
C5	LWLG cannot scale engineering to onboard new customers	M	M	LeMaitre publicly stated this is the bottleneck; hiring path unclear; affects pipeline acceleration
C6	First Stage-4 customer terminates after volume ramp begins	L	H	Long-tail risk; would devastate equity narrative

Foundry / partner risks

#	Risk	Likelihood	Impact	Notes / mitigants
F1	GF de-prioritizes Fotonix / AMF integration	L	H	GF acquired AMF Nov 17 2025; signaling commitment, but corporate priorities can shift
F2	Tower / SilTerra capacity-constrained for LWLG flows	M	M	Foundry capacity is a real industry constraint in 2026-2028
F3	Foundry exclusivity demands compress LWLG pricing	M-H	M	LWLG has historically not granted exclusivity; risk increases as customer urgency rises
F4	Marvell-Polariton transaction post-merger integration delays	M	M-L	Affects POH revenue path; LWLG remains the polymer feed regardless
F5	Synopsys/EDA flow misalignment with LWLG PDK	L	M	Synopsys has been publicly supportive (PECC 2024); low likelihood

Capital / governance risks

#	Risk	Likelihood	Impact	Notes / mitigants
K1	Required additional dilutive raise H2 2027 if no Stage-4 conversion	M-H	H	Cash to 2028 is conditional on no further surprises; dilution flywheel risk
K2	Roth ATM unfavorable execution at low prices	M	M	$51.4M shelf with $16M+ remaining; price-impact risk on aggressive use
K3	Insider selling without offsetting buying	L-M	M	Recent Form 4 patterns show option exercise + sale; no significant open-market buying
K4	Going-concern / audit-opinion change	L	H	Clean audits historically; pre-revenue + cash burn = continued scrutiny
K5	Patent enforcement litigation (LWLG as defendant or plaintiff)	L	M	22 inventions / 35 US grants but small legal team; risk amplifies as commercialization approaches
K6	Board / executive turnover in transition years	L-M	M	LeMaitre installed Dec 2024; Chowdhury Jan 2026; some integration risk

IP / patent risks

#	Risk	Likelihood	Impact	Notes / mitigants
IP1	Foundational US 8,269,004 expires 2029-03-08	Certain	H	Need to extend royalty model via continuation patents + new chromophore generations before expiry
IP2	NLM Photonics design-around erodes IP moat	M	M-H	Selerion crosslinkable thermoset is genuinely different chemistry; both may co-exist as a duopoly
IP3	Foundry develops in-house polymer chemistry	L-M	H	Foundries historically don’t compete in chemistry; long-cycle risk
IP4	Trade-secret leakage via departing engineers	L	M	LWLG team is ~30 engineers; concentration risk for know-how

Competitive risks

#	Risk	Likelihood	Impact	Notes / mitigants
X1	TFLN locks 1.6T-3.2T window before EOP commercializes	M-H	H	The single most important competitive risk
X2	BTO platform progresses faster than expected	L	M	TRL 4-5 today; 5+ year horizon to compete
X3	InP scales beyond 150mm wafers	L	L-M	Long history of failed attempts
X4	Plasmonic-organic hybrid (Polariton/Marvell) absorbs LWLG-supplied stack rather than expanding it	L	M	LeMaitre/Chowdhury LinkedIn engagement suggests partnership not absorption
X5	New EO material (e.g., 2D / nanophotonic) emerges	L	M-H	Long-shot; would disrupt LWLG at the platform level

Market / macro risks

#	Risk	Likelihood	Impact	Notes / mitigants
M1	AI capex pulls back materially in 2026-2027	L-M	H	NVDA $7.7B optical commitments + hyperscaler capex guidance argues against
M2	Recession / liquidity drain affects pre-revenue smallcaps	M	H	High-beta exposure; macro-driven
M3	Russell index removal	L	M-H	Risk if performance lags; conversely Russell inclusion is a catalyst
M4	Short squeeze unwind dynamic	L-M	M	14.67M short shares; could cut both ways
M5	Sector rotation away from “speculative AI plays”	M	M	Macro-narrative risk

Top 5 most consequential risks (combined likelihood × impact)

C2 — Customer Stage-3 takes 24-30 months instead of 12-18 (M-H × M = high consequence)
X1 — TFLN locks volume window before EOP commercializes (M-H × H = highest consequence)
K1 — Required additional dilutive raise if Stage-4 delayed (M-H × H = highest consequence)
IP1 — Foundational patent 2029-03-08 expiry (Certain × H = highest consequence)
T6 — TFLN cost-curve descends faster than EOP (M-H × M-H = high consequence)

What materially de-risks LWLG (in order of importance)

First Stage-3 → Stage-4 transition with named customer
New continuation patent grants extending IP moat past 2029
Royalty/licensing terms publicly disclosed
Operating cash flow turn (likely 2027-2028)
Strategic transaction (acquisition or licensing partnership) at premium

Sources

LWLG SEC filings (10-Q Q3 2025, Form 4 filings, prospectus supplements)
LWLG investor deck Jan 2026
OFC 2026 panel transcripts
USPTO patent records (US 8,269,004 expiration)
NLM Photonics published material specs
IH community discussion of short interest, ATM, dilution